RecruitingEarly Phase 1NCT06197308

Evaluation of an Oral Microbiota-based Therapeutic as a Treatment Option for PSC

Studying Primary sclerosing cholangitis

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
University of Minnesota
Principal Investigator
Elizabeth Aby
University of Minnesota
Intervention
oral vancomycin and oral amoxicillin(drug)
Enrollment
28 enrolled
Eligibility
18-76 years · All sexes
Timeline
20242027

Study locations (1)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT06197308 on ClinicalTrials.gov

Other trials for Primary sclerosing cholangitis

Additional recruiting or active studies for the same condition.

See all trials for Primary sclerosing cholangitis

← Back to all trials